AURA Live signals | Maximize Profits with Getagraph.com

SELL 103434 min ago

@ $8.31

Issued: 14 Feb 2024 @ 15:25

Return: -14.50%

Previous signal: Feb 13 - 09:30

Previous signal: Buy

Return: -2.12 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 12:13):

Stats
Today's Volume	59 791.00
Average Volume	183 903
Market Cap	351.73M
EPS	$0 ( 2024-03-27 )
Next earnings date	( $-0.510 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.70
ATR14	$0.0240 (0.34%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-02	Kilroy Conor	Buy	144 000	Stock Option (Right to Buy)
2024-04-02	Kilroy Conor	Buy	96 000	Common Stock
2024-04-01	Kilroy Conor	Buy	0
2024-03-15	Plavsic Mark	Sell	0	Common Stock
2024-03-15	Plavsic Mark	Sell	138 000	Stock Option (Right to Buy)

INSIDER POWER
86.91
Last 96 transactions
Buy: 15 662 380 \| Sell: 3 253 163

Volume Correlation

Long: -0.09 (neutral)

Short: -0.32 (neutral)

Signal:(57.94) Neutral

Aura Biosciences, Inc. Correlation

10 Most Positive Correlations
PAIC	0.96
SVAC	0.933
LYEL	0.929
GRNV	0.926
ANGI	0.922
WISA	0.918
EPZM	0.918
CNCE	0.915
GERN	0.91
QLGN	0.909

10 Most Negative Correlations
NETE	-0.951
MMAC	-0.925
TGLS	-0.92
BNIXU	-0.919
AMRB	-0.918
PMTS	-0.912
LYTS	-0.912
IBEX	-0.907
LRFC	-0.906
SCPL	-0.906

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aura Biosciences, Inc. Correlation - Currency/Commodity

-0.13
( neutral )

0.23
( neutral )

0.00
( neutral )

0.11
( neutral )

0.03
( neutral )

Aura Biosciences, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.30M (0.00 %)
EPS:	$-1.930

FY	2023
Revenue:	$0
Gross Profit:	$-1.30M (0.00 %)
EPS:	$-1.930

FY	2022
Revenue:	$0
Gross Profit:	$-1.18M (0.00 %)
EPS:	$-1.910

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Aura Biosciences, Inc.

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.